Gupta, P. K., Dutta, S., Kala, S., Nekkanti, M., Desai, S. C., Mahapatra, S. S., . . . Udaykumar, K. (2021). Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease. Wiley.
Chicago Style (17th ed.) CitationGupta, Pawan Kumar, et al. Phase IV Postmarketing Surveillance Study Shows Continued Efficacy and Safety of Stempeucel in Patients with Critical Limb Ischemia Due to Buerger's Disease. Wiley, 2021.
MLA (8th ed.) CitationGupta, Pawan Kumar, et al. Phase IV Postmarketing Surveillance Study Shows Continued Efficacy and Safety of Stempeucel in Patients with Critical Limb Ischemia Due to Buerger's Disease. Wiley, 2021.
Warning: These citations may not always be 100% accurate.